Second opinion
Requesting a second opinion Second opinion Every year, many patients request a second opinion from the multidisciplinary team of the Institut Jules Bordet. Why ask the Institut Jules Bordet for a second opinion? ...
Grande avancée dans la recherche sur les cancers du sein multifocaux
Une analyse plus approfondie des lésions pour une meilleure réponse aux traitements.
Major advance in research regarding lobular breast cancer
A better molecular characterisation of lobular breast cancers to optimise patient care.
Présidence de l’OECI : le Dr D. de Valeriola
La présidence de l’OECI est confiée au Dr D. de Valeriola, Directeur Général Médical de l’Institut Jules Bordet.
Une simple prise de sang pour caractériser un cancer du sein
Les chercheurs de l’Institut Jules Bordet avancent à grands pas dans cette direction.
IMPAKT 2017
IMPAKT 2017 A great IMPAKT meeting in Brussels on 4-6 May 2017 in Brussels.These few words to remind you that there will be a great IMPAKT meeting in Brussels on 4‐6 May 2017 in Brussels.
Targeted cancer therapies : less toxic and more effective ?
Targeted cancer therapies : less toxic and more effective ? Discover Prof Bron's presentation at the "Collège de Belgique" on 30/10/2016 : watch the video
Viva - Gala for the profit of the "Amis"
13/11/2017 : Concert-spectacle around Vivaldi - Original idea of Vincent Engel
Viral leukemia, monitor therapeutic response
Press release (05/09/2017) Novel tool to monitor therapeutic response of patients with viral leukemia
Imane Bachir
Department :
Anaesthesiology and Intensive Care
Martial Bodo
Department :
Psycho-oncology
, Cancer Prevention and Screening
Cindy Borghraef
Department :
Psycho-oncology
France Delevallez
Department :
Psycho-oncology
Florence Lewis
Department :
Psycho-oncology
Aurore Liénard
Department :
Psycho-oncology